Is Osteoporosis Disease Management Cost Effective?

Overview

Journal Curr Osteoporos Rep

Publisher Current Science

Specialties Endocrinology
Orthopedics

Date 2010 Apr 29

PMID 20425091

Citations 17

Authors

Richard Dell

Denise Greene

Affiliations

Soon will be listed here.

Abstract

Can osteoporosis disease management be cost effective? To answer that question, we conducted an extensive review of osteoporosis and fragility fracture prevention literature in peer-reviewed scientific journals and evidence-based guidelines from professional societies and government health organizations. We explored different strategies suggested by the literature to find how programs can be structured to be cost effective and to decrease fracture rates. We focused on ways to cost effectively identify, risk stratify, treat, and then track patients at risk for osteoporosis and fragility fractures. Studies have shown that osteoporosis management can decrease the hip fracture rate by 25% to 50% and be cost effective at the same time.

Citing Articles

Association between vertebral bone quality score and residual back pain following percutaneous vertebroplasty for osteoporotic vertebral compression fractures.

Chen C, Wu B, Yu H, Dai Z, Yan L, Cai D Eur Spine J. 2024; 34(2):537-545.

PMID: 39688705 DOI: 10.1007/s00586-024-08619-6.

Vertebral bone quality score as a new tool for osteoporosis diagnosis in patients undergoing lumbosacral fusion surgery: a single center cohort study.

Najafi A, Bagheri A, Hadavi D, Mobedi A, Azarsina S, Chaghamirzayi P Eur J Transl Myol. 2024; 34(4.

PMID: 39283159 PMC: 11726176. DOI: 10.4081/ejtm.2024.12311.

Factors associated with non-adherence to dual-energy x-ray absorptiometry screening during the COVID-19 pandemic in an academic medical center.

Shi Q, Cheah J, Zai A Arch Osteoporos. 2024; 19(1):66.

PMID: 39080113 DOI: 10.1007/s11657-024-01430-2.

Opportunistic prediction of osteoporosis in patients with degenerative lumbar diseases: a simplified T12 vertebral bone quality approach.

Xue C, Lu X, Sun G, Wang N, He G, Xu W J Orthop Surg Res. 2024; 19(1):296.

PMID: 38750513 PMC: 11094894. DOI: 10.1186/s13018-024-04782-0.

Different cervical vertebral bone quality scores for bone mineral density assessment for the patients with cervical degenerative disease undergoing ACCF/ACDF: computed tomography and magnetic resonance imaging-based study.

Wang Z, Zhang J, Chen Q, Huang Y, Song Y, Liu L J Orthop Surg Res. 2023; 18(1):927.

PMID: 38053202 PMC: 10699045. DOI: 10.1186/s13018-023-04422-z.

References

Dawson-Hughes B, Tosteson A, Melton 3rd L, Baim S, Favus M, Khosla S . Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int. 2008; 19(4):449-58. DOI: 10.1007/s00198-008-0559-5. View

Kanis J, Compston J . NICE continues to muddy the waters of osteoporosis. Osteoporos Int. 2008; 19(8):1105-7. DOI: 10.1007/s00198-008-0649-4. View

Tosteson A, Burge R, Marshall D, Lindsay R . Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. Am J Manag Care. 2008; 14(9):605-15. View

Curtis J, Adachi J, Saag K . Bridging the osteoporosis quality chasm. J Bone Miner Res. 2008; 24(1):3-7. DOI: 10.1359/jbmr.081116. View

Newman E, Ayoub W, STARKEY R, Diehl J, Wood G . Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int. 2003; 14(2):146-51. DOI: 10.1007/s00198-002-1336-5. View

Harrington J, Barash H, Day S, Lease J . Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum. 2005; 53(2):198-204. DOI: 10.1002/art.21072. View

Kanis J, Adams J, Borgstrom F, Cooper C, Jonsson B, Preedy D . The cost-effectiveness of alendronate in the management of osteoporosis. Bone. 2007; 42(1):4-15. DOI: 10.1016/j.bone.2007.10.019. View

Ayoub W, Newman E, Blosky M, Stewart W, Wood G . Improving detection and treatment of osteoporosis: redesigning care using the electronic medical record and shared medical appointments. Osteoporos Int. 2008; 20(1):37-42. DOI: 10.1007/s00198-008-0635-x. View

Donaldson M, Cawthon P, Lui L, Schousboe J, Ensrud K, Taylor B . Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2008; 24(4):675-80. PMC: 2659514. DOI: 10.1359/jbmr.081203. View

10.

Moayyeri A . Identification of factors influencing the intervention thresholds for treatment of osteoporosis based on 10-year absolute fracture risks. J Clin Densitom. 2008; 12(1):1-4. DOI: 10.1016/j.jocd.2008.10.001. View

11.

Dell R, Greene D, Schelkun S, Williams K . Osteoporosis disease management: the role of the orthopaedic surgeon. J Bone Joint Surg Am. 2008; 90 Suppl 4:188-94. DOI: 10.2106/JBJS.H.00628. View

12.

van Staa T, Kanis J, Geusens P, Boonen A, Leufkens H, Cooper C . The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks. Value Health. 2007; 10(5):348-57. DOI: 10.1111/j.1524-4733.2007.00188.x. View

13.

Kanis J, McCloskey E, Johansson H, Oden A . Approaches to the targeting of treatment for osteoporosis. Nat Rev Rheumatol. 2009; 5(8):425-31. DOI: 10.1038/nrrheum.2009.139. View

14.

Schuit S, van der Klift M, Weel A, de Laet C, Burger H, Seeman E . Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004; 34(1):195-202. DOI: 10.1016/j.bone.2003.10.001. View

15.

Geusens P, Dumitrescu B, van Geel T, van Helden S, Vanhoof J, Dinant G . Impact of systematic implementation of a clinical case finding strategy on diagnosis and therapy of postmenopausal osteoporosis. J Bone Miner Res. 2008; 23(6):812-8. DOI: 10.1359/jbmr.080212. View

16.

Compston J, Cooper A, Cooper C, Francis R, Kanis J, Marsh D . Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas. 2009; 62(2):105-8. DOI: 10.1016/j.maturitas.2008.11.022. View

17.

Kurup H, Andrew J . Secondary prevention of osteoporosis after Colles fracture: Current practice. Joint Bone Spine. 2007; 75(1):50-2. DOI: 10.1016/j.jbspin.2007.01.043. View

18.

Schousboe J, Ensrud K, Nyman J, Melton 3rd L, Kane R . Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc. 2005; 53(10):1697-704. DOI: 10.1111/j.1532-5415.2005.53504.x. View

19.

Tosteson A, Melton 3rd L, Dawson-Hughes B, Baim S, Favus M, Khosla S . Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008; 19(4):437-47. PMC: 2729707. DOI: 10.1007/s00198-007-0550-6. View

20.

Leslie W, ODonnell S, Jean S, Lagace C, Walsh P, Bancej C . Trends in hip fracture rates in Canada. JAMA. 2009; 302(8):883-9. DOI: 10.1001/jama.2009.1231. View